Ignite Creation Date:
2024-05-05 @ 12:11 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00268359
Status:
COMPLETED
Last Update Posted:
2014-07-21
First Post:
2005-12-20
Brief Title:
Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas
Sponsor:
Duke University
Organization:
Duke University